Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?
Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?
Date
09 Oct 2016Session
Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?Presenters
Jacob SchachterAuthors
J. SchachterAuthor affiliations
- Ella Institute of Melanoma, Sheba Cancer Research Center, 52621 - Tel Hashomer/IL
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.